Literature DB >> 36116835

Lyme Arthritis.

Sheila L Arvikar1, Allen C Steere2.   

Abstract

Arthritis is the most common late manifestation of Borrelia burgdorferi infection in the United States, usually beginning months after the tick bite. In most patients with Lyme arthritis (LA) today, arthritis is the presenting manifestation of the disease. Patients have swelling and pain in one or a few large joints, especially the knee. Serologic testing is the mainstay of diagnosis. Responses to antibiotic treatment are generally excellent, although a small percentage of patients have persistent, postinfectious synovitis after 2 to 3 months of oral and IV antibiotics, which respond to anti-inflammatory therapies. Herein we review the clinical presentation, diagnosis, and management of LA.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Borrelia burgdorferi; Inflammatory arthritis; Lyme arthritis; Lyme disease; Postantibiotic arthritis; Postinfectious arthritis

Mesh:

Substances:

Year:  2022        PMID: 36116835      PMCID: PMC9533683          DOI: 10.1016/j.idc.2022.03.006

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.905


  58 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis.

Authors:  Shiqian Shen; Junghee J Shin; Klemen Strle; Gail McHugh; Xin Li; Lisa J Glickstein; Elise E Drouin; Allen C Steere
Journal:  Arthritis Rheum       Date:  2010-07

Review 3.  Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.

Authors:  Allen C Steere; Sheryn M Angelis
Journal:  Arthritis Rheum       Date:  2006-10

4.  Intraarticular corticosteroids in refractory childhood Lyme arthritis.

Authors:  S Nimmrich; I Becker; G Horneff
Journal:  Rheumatol Int       Date:  2014-01-04       Impact factor: 2.631

5.  Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease.

Authors:  R B Nadelman; S W Luger; E Frank; M Wisniewski; J J Collins; G P Wormser
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

6.  Pediatric Antibiotic-refractory Lyme Arthritis: A Multicenter Case-control Study.

Authors:  Daniel B Horton; Alysha J Taxter; Amy L Davidow; Brandt Groh; David D Sherry; Carlos D Rose
Journal:  J Rheumatol       Date:  2019-03-01       Impact factor: 4.666

7.  Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.

Authors:  Gary P Wormser; Dustin Brisson; Dionysios Liveris; Klára Hanincová; Sabina Sandigursky; John Nowakowski; Robert B Nadelman; Sara Ludin; Ira Schwartz
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

8.  Borrelia burgdorferi in joint fluid in chronic Lyme arthritis.

Authors:  D R Snydman; D P Schenkein; V P Berardi; C C Lastavica; K M Pariser
Journal:  Ann Intern Med       Date:  1986-06       Impact factor: 25.391

9.  The clinical evolution of Lyme arthritis.

Authors:  A C Steere; R T Schoen; E Taylor
Journal:  Ann Intern Med       Date:  1987-11       Impact factor: 25.391

10.  Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis.

Authors:  Brandon L Jutras; Robert B Lochhead; Zachary A Kloos; Jacob Biboy; Klemen Strle; Carmen J Booth; Sander K Govers; Joe Gray; Peter Schumann; Waldemar Vollmer; Linda K Bockenstedt; Allen C Steere; Christine Jacobs-Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.